News » MHRA alert » Alert: Erythrocin 250 tablets
July 2nd 2025
Amdipharm UK Ltd has issued an alert for one batch of erythromycin stearate BP 250mg tablets (Erythrocin 250 tablets) due to a faulty PIL.
The affected batch is
| Batch No. | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| 6104532 | 08/2028 | 100 Tablets/pack | 04/09/2024 |
The superseded PIL used in Batch 6104532 is missing important updated safety information from section 2 of the PIL: What you need to know before you take Erythrocin® Tablets.
Updated PILs are available from the electronic medicines compendium (eMC) and on request from medicalinformation@advanzpharma.com or telephone +44 (0) 208 588 9131..
Dispensary teams are asked to supply this medicine with an updated PIL.
For medical information enquiries please email medicalinformation@advanzpharma.com, or telephone +44 (0) 208 588 9131
For stock control enquiries please email custcustomercare@advanzpharma.com or telephone 0208 588 9441
